Nottingham Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $242K | Sell |
|
|||||
2024
Q4 | $835K | Sell |
|
|||||
2024
Q3 | $1.62M | Sell |
|
|||||
2024
Q2 | $1.32M | Hold |
|
|||||
2024
Q1 | $1.76M | Sell |
|
|||||
2023
Q4 | $866K | Hold |
|
|||||
2023
Q3 | $610K | Hold |
|
|||||
2023
Q2 | $1M | Hold |
|
|||||
2023
Q1 | $1.02M | Hold |
|
|||||
2022
Q4 | $546K | Hold |
|
|||||
2022
Q3 | $806K | Hold |
|
|||||
2022
Q2 | $781K | Hold |
|
|||||
2022
Q1 | $962K | Hold |
|
|||||
2021
Q4 | $1.35M | Hold |
|
|||||
2021
Q3 | $1.94M | Hold |
|
|||||
2021
Q2 | $2.75M | Hold |
|
|||||
2021
Q1 | $3.19M | Sell |
|
|||||
2020
Q4 | $4.05M | Hold |
|
|||||
2020
Q3 | $1.49M | Hold |
|
|||||
2020
Q2 | $1.48K | Buy |
|
|||||
2020
Q1 | $747K | Hold |
|
|||||
2019
Q4 | $596K | Sell |
|
|||||
2019
Q3 | $595K | Buy |
|
|||||
2019
Q2 | $647K | Hold |
|
|||||
2019
Q1 | $583K | Hold |
|
|||||
2018
Q4 | $1.01M | Hold |
|
|||||
2018
Q3 | $1.01M | Hold |
|
|||||
2018
Q2 | $957K | Hold |
|
|||||
2018
Q1 | $957K | Hold |
|
|||||
2017
Q4 | $654K | Buy |
|
|||||
2017
Q3 | $893K | Hold |
|
|||||
2017
Q2 | $1.34M | Hold |
|
|||||
2017
Q1 | $1.34M | Hold |
|
|||||
2016
Q4 | $1.21M | Sell |
|
|||||
2016
Q3 | $1.3M | Hold |
|
|||||
2016
Q2 | $937K | Buy |
|
|||||
2016
Q1 | $1.71M | Hold |
|
|||||
2015
Q4 | $1.71M | Sell |
|
|||||
2015
Q3 | $2.6M | Buy |
|
|||||
2015
Q2 | $3.62M | Buy |
|
|||||
2015
Q1 | $6.87M | Buy |
|